Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 3
2012 4
2013 11
2014 15
2015 23
2016 26
2017 21
2018 37
2019 42
2020 38
2021 30
2022 21
2023 8
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 29686147

251 results

Results by year

Filters applied: . Clear all
Page 1
In Vitro Activity of Ceftazidime-Avibactam against Isolates from Respiratory and Blood Specimens from Patients with Nosocomial Pneumonia, Including Ventilator-Associated Pneumonia, in a Phase 3 Clinical Trial.
Stone GG, Bradford PA, Tawadrous M, Taylor D, Cadatal MJ, Chen Z, Chow JW. Stone GG, et al. Antimicrob Agents Chemother. 2020 Apr 21;64(5):e02356-19. doi: 10.1128/AAC.02356-19. Print 2020 Apr 21. Antimicrob Agents Chemother. 2020. PMID: 32071051 Free PMC article. Clinical Trial.
In Vitro Activity of Ceftazidime-Avibactam against Isolates in a Phase 3 Open-Label Clinical Trial for Complicated Intra-Abdominal and Urinary Tract Infections Caused by Ceftazidime-Nonsusceptible Gram-Negative Pathogens.
Stone GG, Bradford PA, Newell P, Wardman A. Stone GG, et al. Antimicrob Agents Chemother. 2017 Jan 24;61(2):e01820-16. doi: 10.1128/AAC.01820-16. Print 2017 Feb. Antimicrob Agents Chemother. 2017. PMID: 27872067 Free PMC article. Clinical Trial.
Molecular β-Lactamase Characterization of Aerobic Gram-Negative Pathogens Recovered from Patients Enrolled in the Ceftazidime-Avibactam Phase 3 Trials for Complicated Intra-abdominal Infections, with Efficacies Analyzed against Susceptible and Resistant Subsets.
Mendes RE, Castanheira M, Woosley LN, Stone GG, Bradford PA, Flamm RK. Mendes RE, et al. Antimicrob Agents Chemother. 2017 May 24;61(6):e02447-16. doi: 10.1128/AAC.02447-16. Print 2017 Jun. Antimicrob Agents Chemother. 2017. PMID: 28348155 Free PMC article. Clinical Trial.
In Vitro Activity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Asia-Pacific Countries: Results from the INFORM Global Surveillance Program, 2012 to 2015.
Karlowsky JA, Kazmierczak KM, Bouchillon SK, de Jonge BLM, Stone GG, Sahm DF. Karlowsky JA, et al. Antimicrob Agents Chemother. 2018 Jun 26;62(7):e02569-17. doi: 10.1128/AAC.02569-17. Print 2018 Jul. Antimicrob Agents Chemother. 2018. PMID: 29760124 Free PMC article.
Results from the China Antimicrobial Surveillance Network (CHINET) in 2017 of the In Vitro Activities of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa.
Yin D, Wu S, Yang Y, Shi Q, Dong D, Zhu D, Hu F; China Antimicrobial Surveillance Network (CHINET) Study Group. Yin D, et al. Antimicrob Agents Chemother. 2019 Mar 27;63(4):e02431-18. doi: 10.1128/AAC.02431-18. Print 2019 Apr. Antimicrob Agents Chemother. 2019. PMID: 30617091 Free PMC article.
251 results